Skip to main content
Caplight Logo









Find Therapeutics

Find Therapeutics

Private
MontrealHealthcare & Life Scienceshttps://www.findtherapeutics.com/

Last Round

Convertible Debt

Sep 16, 2024

Total Funding Raised

$8.1M

Company Overview

Find Therapeutics is a clinical-stage biopharmaceutical company that develops next-generation therapies for demyelinating diseases such as Chronic Optic Neuropathy and Multiple Sclerosis.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalpeptide therapyremyelinationdemyelinating diseasesdrug discoveryclinical-stage biotechmultiple sclerosisbiotech startuptherapeutic peptidemembrane receptorschronic optic neuropathydrug developmentbiotech pipelinemyelin repairclinical trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Find Therapeutics Comparables

Compare Find Therapeutics with similar companies based on industry and business-model similarity.

Find Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Progentos Therapeutics
85%
Rewind Therapeutics
85%
Convelo Therapeutics
84%

Find Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtSep 16, 2024
SeedJun 8, 2020

Find Therapeutics Investors

Notable investors and investment history

Find Therapeutics investors
InvestorRounds
CTI Life Sciences FundConvertible Debt
Investissement QuébecConvertible Debt
adMare BioInnovationsConvertible Debt, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    Monthly visitors increased 210% MoM.

  • Jan 9, 2026

    Paul F. Truex steps down as Executive Chairman, remains on Board.

Find Therapeutics Filings

Explore SEC and related filing metadata, where available.

Find Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Find Therapeutics's valuation, stock price, and market status.

Is Find Therapeutics a public or private company?

Find Therapeutics is a private company.

What is the current stock price of Find Therapeutics?

Find Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Find Therapeutics worth (valuation)?

Valuation information for Find Therapeutics is not publicly available.

Can I buy Find Therapeutics stock?

Find Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Find Therapeutics's last funding round?

Find Therapeutics's most recent funding round was Convertible Debt on September 16, 2024.

Who are the main investors in Find Therapeutics?

Key investors in Find Therapeutics include Investissement Québec.

Will Find Therapeutics IPO soon?

No public IPO plans have been announced for Find Therapeutics.

How can I track Find Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Find Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMontreal
Employee Range9
Year Founded2020
Last FundingSep 16, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?